Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine

Rajasekaran A, Julian BA, Rizk DV (2021) IgA nephropathy: an interesting autoimmune kidney disease. Am J Med Sci 361:176–194

Article  PubMed  Google Scholar 

Lai KN (2012) Pathogenesis of IgA nephropathy. Nat Rev Nephrol 8:275–283

Article  CAS  PubMed  Google Scholar 

Saha MK, Julian BA, Novak J, Rizk DV (2018) Secondary IgA nephropathy. Kidney Int 94:674–681

Article  PubMed  PubMed Central  Google Scholar 

Silva FG, Chander P, Pirani CL, Hardy MA (1982) Disappearance of glomerular mesangial IgA deposits after renal allograft transplantation. Transplantation 33:241–246

CAS  PubMed  Google Scholar 

Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, Steenkamp R, Wong K, Turner AN, Wang K, Gale DP, Barratt J (2023) Long-term outcomes in IgA nephropathy. Clin J Am Soc Nephrol 18:727–738

Article  PubMed  PubMed Central  Google Scholar 

Kawabe M, Yamamoto I (2023) Current status and perspectives on recurrent IgA nephropathy after kidney transplantation. Nephron 147(Suppl 1):9–13

Article  CAS  PubMed  Google Scholar 

Uffing A, Pérez-Saéz MJ, Jouve T, Bugnazet M, Malvezzi P, Muhsin SA, Lafargue MC, Reindl-Schwaighofer R, Morlock A, Oberbauer R, Buxeda A, Burballa C, Pascual J, von Moos S, Seeger H, La Manna G, Comai G, Bini C, Russo LS, Farouk S, Nissaisorakarn P, Patel H, Agrawal N, Mastroianni-Kirsztajn G, Mansur J, Tedesco-Silva H, Ventura CG, Agena F, David-Neto E, Akalin E, Alani O, Mazzali M, Manfro RC, Bauer AC, Wang AX, Cheng XS, Schold JD, Berger SP, Cravedi P, Riella LV (2021) Recurrence of IgA nephropathy after kidney transplantation in adults. Clin J Am Soc Nephrol 16:1247–1255

Article  CAS  PubMed  PubMed Central  Google Scholar 

Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ (2002) Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 347:103–109

Article  PubMed  Google Scholar 

O’Shaughnessy MM, Liu S, Montez-Rath ME, Lenihan CR, Lafayette RA, Winkelmayer WC (2017) Kidney transplantation outcomes across GN subtypes in the United States. J Am Soc Nephrol 28:632–644

Article  PubMed  Google Scholar 

Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P (2013) The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival. Nephrol Dial Transplant 28:1305–1314

Article  CAS  PubMed  Google Scholar 

Allen PJ, Chadban SJ, Craig JC, Lim WH, Allen RDM, Clayton PA, Teixeira-Pinto A, Wong G (2017) Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes. Kidney Int 92:461–469

Article  PubMed  Google Scholar 

Cosio FG, Cattran DC (2017) Recent advances in our understanding of recurrent primary glomerulonephritis after kidney transplantation. Kidney Int 91:304–314

Article  PubMed  Google Scholar 

Mohamed MMB, Wickman TJ, Fogo AB, Velez JCQ (2021) De novo Immunoglobulin A vasculitis following exposure to SARS-CoV-2 immunization. Ochsner J 21:395–401

Article  PubMed  PubMed Central  Google Scholar 

Uchiyama Y, Fukasawa H, Ishino Y, Nakagami D, Kaneko M, Yasuda H, Furuya R (2022) Sibling cases of gross hematuria and newly diagnosed IgA nephropathy following SARS-CoV-2 vaccination. BMC Nephrol 23:216

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gesualdo L, Di Leo V, Coppo R (2021) The mucosal immune system and IgA nephropathy. Semin Immunopathol 43:657–668

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vaz de Castro PAS, Amaral AA, Almeida MG, Selvaskandan H, Barratt J, Simoes ESAC (2024) Examining the association between serum galactose-deficient IgA1 and primary IgA nephropathy: a systematic review and meta-analysis. J Nephrol. https://doi.org/10.1007/s40620-023-01874-8

Article  PubMed  Google Scholar 

Kiryluk K, Sanchez-Rodriguez E, Zhou XJ, Zanoni F, Liu L, Mladkova N, Khan A, Marasa M, Zhang JY, Balderes O, Sanna-Cherchi S, Bomback AS, Canetta PA, Appel GB, Radhakrishnan J, Trimarchi H, Sprangers B, Cattran DC, Reich H, Pei Y, Ravani P, Galesic K, Maixnerova D, Tesar V, Stengel B, Metzger M, Canaud G, Maillard N, Berthoux F, Berthelot L, Pillebout E, Monteiro R, Nelson R, Wyatt RJ, Smoyer W, Mahan J, Samhar AA, Hidalgo G, Quiroga A, Weng P, Sreedharan R, Selewski D, Davis K, Kallash M, Vasylyeva TL, Rheault M, Chishti A, Ranch D, Wenderfer SE, Samsonov D, Claes DJ, Akchurin O, Goumenos D, Stangou M, Nagy J, Kovacs T, Fiaccadori E, Amoroso A, Barlassina C, Cusi D, Del Vecchio L, Battaglia GG, Bodria M, Boer E, Bono L, Boscutti G, Caridi G, Lugani F, Ghiggeri G, Coppo R, Peruzzi L, Esposito V, Esposito C, Feriozzi S, Polci R, Frasca G, Galliani M, Garozzo M, Mitrotti A, Gesualdo L, Granata S, Zaza G, Londrino F, Magistroni R, Pisani I, Magnano A, Marcantoni C, Messa P, Mignani R, Pani A, Ponticelli C, Roccatello D, Salvadori M, Salvi E, Santoro D, Gembillo G, Savoldi S, Spotti D, Zamboli P, Izzi C, Alberici F, Delbarba E, Florczak M, Krata N, Mucha K, Pączek L, Niemczyk S, Moszczuk B, Pańczyk-Tomaszewska M, Mizerska-Wasiak M, Perkowska-Ptasińska A, Bączkowska T, Durlik M, Pawlaczyk K, Sikora P, Zaniew M, Kaminska D, Krajewska M, Kuzmiuk-Glembin I, Heleniak Z, Bullo-Piontecka B, Liberek T, Dębska-Slizien A, Hryszko T, Materna-Kiryluk A, Miklaszewska M, Szczepańska M, Dyga K, Machura E, Siniewicz-Luzeńczyk K, Pawlak-Bratkowska M, Tkaczyk M, Runowski D, Kwella N, Drożdż D, Habura I, Kronenberg F, Prikhodina L, van Heel D, Fontaine B, Cotsapas C, Wijmenga C, Franke A, Annese V, Gregersen PK, Parameswaran S, Weirauch M, Kottyan L, Harley JB, Suzuki H, Narita I, Goto S, Lee H, Kim DK, Kim YS, Park JH, Cho B, Choi M, Van Wijk A, Huerta A, Ars E, Ballarin J, Lundberg S, Vogt B, Mani LY, Caliskan Y, Barratt J, Abeygunaratne T, Kalra PA, Gale DP, Panzer U, Rauen T, Floege J, Schlosser P, Ekici AB, Eckardt KU, Chen N, Xie J, Lifton RP, Loos RJF, Kenny EE, Ionita-Laza I, Köttgen A, Julian BA, Novak J, Scolari F, Zhang H, Gharavi AG (2023) Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. Nat Genet 55:1091–1105

Article  CAS  PubMed  Google Scholar 

Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS (2010) Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy. Transpl Int 23:169–175

Article  PubMed  Google Scholar 

Rodas LM, Ruiz-Ortiz E, Garcia-Herrera A, Pereira A, Blasco M, Ventura-Aguiar P, Viñas Gomis O, Egri N, De Sousa E, Palou E, Diekmann F, Poch E, Campistol JM, Quintana LF (2020) IgA nephropathy recurrence after kidney transplantation: role of recipient age and human leukocyte antigen-B mismatch. Am J Nephrol 51:357–365

Article  CAS  PubMed  Google Scholar 

Ahn S, Min SI, Min SK, Ha IS, Kang HG, Kim YS, Kim SJ, Hao J (2015) Different recurrence rates between pediatric and adult renal transplant for immunoglobulin A nephropathy: predictors of posttransplant recurrence. Exp Clin Transplant 13:227–232

PubMed  Google Scholar 

Cazorla-López JM, Wu J, Villanego-Fernández F, Naranjo-Muñoz J, Vigara-Sánchez LA, García-García-Doncel A, Orellana-Chávez C, Moreno-Salazar A, García-Álvarez T, Mazuecos-Blanca A (2020) IgA nephropathy after renal transplant: recurrences and de novo cases. Transplant Proc 52:515–518

Article  PubMed  Google Scholar 

Sato K, Ishida H, Uchida K, Nitta K, Tanabe K (2013) Risk factors for recurrence of immunoglobulin a nephropathy after renal transplantation: single center study. Ther Apher Dial 17:213–220

Article  CAS  PubMed  Google Scholar 

Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F (2015) Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes. Kidney Int 88:815–822

Article  CAS  PubMed  Google Scholar 

Park WY, Kim Y, Paek JH, Jin K, Han S (2021) Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients. Kidney Res Clin Pract 40:317–324

Article  PubMed  PubMed Central  Google Scholar 

Odum J, Peh CA, Clarkson AR, Bannister KM, Seymour AE, Gillis D, Thomas AC, Mathew TH, Woodroffe AJ (1994) Recurrent mesangial IgA nephritis following renal transplantation. Nephrol Dial Transplant 9:309–312

CAS  PubMed  Google Scholar 

Li Y, Tang Y, Lin T, Song T (2023) Risk factors and outcomes of IgA nephropathy recurrence after kidney transplantation: a systematic review and meta-analysis. Front Immunol 14:1277017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bai J, Wu Q, Chen J, Zheng Z, Chang J, Wang L, Zhou Y, Guo Q (2023) Risk factors for recurrent IgA nephropathy after renal transplantation: a meta-analysis. Biomol Biomed 23:364–375

CAS  PubMed  PubMed Central  Google Scholar 

Von Visger JR, Gunay Y, Andreoni KA, Bhatt UY, Nori US, Pesavento TE, Elkhammas EA, Winters HA, Nadasdy T, Singh N (2014) The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression. Clin Transplant 28:845–854

Article 

留言 (0)

沒有登入
gif